K KNOA PHARMA
Live / Applied — Third extension granted (statement of use) (as of 19 Nov 2025)
What this means for you
Not registered yet, but its 18 Nov 2021 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97132159
- Mark type
- Word mark
- Filed
- 18 Nov 2021
- Published for opposition
- 02 May 2023
- Attorney of record
- FARA S. SUNDERJI
Goods and services
- Class 005 — Pharmaceuticals: A house mark for a full line of pharmaceuticals; pharmaceuticals for use in the treatment of central nervous system disorders, pain, opioid overdose, opioid reversal, opioid use disorders, interstitial cystitis/bladder pain syndrome (IC/BPS), Overactive Bladder (OAB), Alcohol Use Disorder, Substance Use Disorder, sleep disorders including Insomnia Associated with Alcohol Cessation (IAAC), anaphylaxis; pharmaceuticals for use in the treatment of oncology conditions, specifically glioblastoma multiforme (GBM), non Hodgkin lymphoma, solid tumors, melanoma, chronic myelogenous leukemia, hemato-oncology, refractory/relapsed malignancies, alone or in combination with other agents; analgesics; pharmaceuticals, namely, opioid antagonists; syringes filled with pharmaceuticals for use in the treatment of opioid overdose, opioid reversal, or opioid use disorders; syringes filled with opioid antagonists; injectors filled with pharmaceuticals for use in the treatment of opioid overdose, opioid reversal, or opioid use disorders; injectors filled with opioid antagonists; injectable pharmaceuticals for use in the treatment of opioid overdose, opioid reversal, or opioid use disorders; injectable pharmaceuticals, namely, opioid antagonists
- Class 042 — Scientific and technological services: Pharmaceutical research and development
Owner
- Purdue Pharma L.P., Stamford, CT, US
- Purdue Pharma L.P., Stamford, CT, US
Prosecution history
- 20 Nov 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 19 Nov 2025 — SOU EXTENSION 3 GRANTED
- 19 Nov 2025 — SOU EXTENSION 3 FILED
- 19 Nov 2025 — SOU TEAS EXTENSION RECEIVED
- 06 May 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 06 May 2025 — SOU EXTENSION 2 GRANTED
- 05 May 2025 — SOU EXTENSION 2 FILED
- 05 May 2025 — SOU TEAS EXTENSION RECEIVED
- 07 Oct 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 07 Oct 2024 — SOU EXTENSION 1 GRANTED
- 07 Oct 2024 — SOU EXTENSION 1 FILED
- 07 Oct 2024 — SOU TEAS EXTENSION RECEIVED
- 04 Jun 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 12 Apr 2024 — TTAB RELEASE CASE TO TRADEMARKS
- 12 Apr 2024 — OPPOSITION TERMINATED NO. 999999